Oppenheimer Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $883K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.14M | Buy |
|
|||||
|
2024
Q2 | $945K | Buy |
|
|||||
|
2024
Q1 | $738K | Sell |
|
|||||
|
2023
Q4 | $631K | Sell |
|
|||||
|
2023
Q3 | $495K | Sell |
|
|||||
|
2023
Q2 | $497K | Sell |
|
|||||
|
2023
Q1 | $620K | Sell |
|
|||||
|
2022
Q4 | $719K | Sell |
|
|||||
|
2022
Q3 | $772K | Sell |
|
|||||
|
2022
Q2 | $721K | Sell |
|
|||||
|
2022
Q1 | $1.33M | Sell |
|
|||||
|
2021
Q4 | $1.62M | Sell |
|
|||||
|
2021
Q3 | $2.1M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Buy |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $748K | Buy |
|
|||||
|
2020
Q3 | $363K | Buy |
|
|||||
|
2020
Q2 | $200K | Buy |
|
|||||
|
2020
Q1 | $49K | Buy |
|